SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:his-8597"
 

Sökning: id:"swepub:oai:DiVA.org:his-8597" > Drug metabolizing e...

Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells

Ulvestad, Maria (författare)
AstraZeneca, Sweden / Cellectis AB, Sweden / University of Oslo, Norway
Nordell, Pär (författare)
AstraZeneca, Sweden
Asplund, Annika (författare)
Cellectis AB, Sweden
visa fler...
Rehnström, Marie (författare)
Cellectis AB, Sweden
Jacobsson, Susanna (författare)
Cellectis AB, Sweden
Holmgren, Gustav (författare)
Högskolan i Skövde,Institutionen för vård och natur,Forskningscentrum för Systembiologi,Cellectis AB, Sweden / Sahlgrenska University Hospital, Sweden
Davidson, Lindsay (författare)
University of Dundee, Scotland
Brolén, Gabriella (författare)
AstraZeneca, Sweden
Edsbagge, Josefina (författare)
Cellectis AB, Sweden
Björquist, Petter (författare)
Cellectis AB, Sweden
Küppers-Munther, Barbara (författare)
Högskolan i Skövde,Institutionen för vård och natur,Forskningscentrum för Systembiologi,Cellectis AB, Sweden
Andersson, Tommy B. (författare)
AstraZeneca, Sweden / Karolinska Institute, Sweden
visa färre...
 (creator_code:org_t)
Elsevier, 2013
2013
Engelska.
Ingår i: Biochemical Pharmacology. - : Elsevier. - 0006-2952 .- 1356-1839 .- 1873-2968. ; 86:5, s. 691-702
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Human embryonic and induced pluripotent stem cell-derived hepatocytes (hESC-Hep and hiPSC-Hep) have the potential to provide relevant human in vitro model systems for toxicity testing and drug discovery studies. In this study, the expression and function of important drug metabolizing cytochrome P450 (CYP) enzymes and transporter proteins in hESC-Hep and hiPSC-Hep were compared to cryopreserved human primary hepatocytes (hphep) and HepG2 cells. Overall, CYP activities in hESC-Hep and hiPSC-Hep were much lower than in hphep cultured for 4 h, but CYP1A and 3A activities were comparable to levels in hphep cultured for 48 h (CYP1A: 35% and 26% of 48 h hphep, respectively; CYP3A: 80% and 440% of 48 h hphep, respectively). Importantly, in hESC-Hep and hiPSC-Hep, CYP activities were stable or increasing for at least one week in culture which was in contrast to the rapid loss of CYP activities in cultured hphep between 4 and 48 h after plating. With regard to transporters, in hESC-Hep and hiPSC-Hep, pronounced NTCP activity (17% and 29% of 4 h hphep, respectively) and moderate BSEP activity (6% and 8% of 4 h hphep, respectively) were observed. Analyses of mRNA expression and immunocytochemistry supported the observed CYP and transporter activities and showed expression of additional CYPs and transporters. In conclusion, the stable expression and function of CYPs and transporters in hESC-Hep and hiPSC-Hep for at least one week opens up the possibility to reproducibly perform long term and extensive studies, e.g. chronic toxicity testing, in a stem cell-derived hepatic system. (C) 2013 Elsevier Inc. All rights reserved.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)

Nyckelord

Human embryonic stem cell-derived hepatocytes
Human induced pluripotent stem cell- derived hepatocytes
Cytochrome P450
Transporter proteins
Hepatocytes
Naturvetenskap
Natural sciences

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy